Introduction {#s0001}
============

Parvoviruses (family *Parvoviridae*) and their associated diseases affect various carnivores including felids and canids (Siegl et al. [@CIT0024]). Feline panleucopaenia virus (FPLV) infection was one of the first viral diseases identified in domestic cats (*Felis catus*), during the 1930s and 1940s, and also infects non-domestic felids (Parrish [@CIT0019]). At roughly the same time (\~1947), parvoviral gastroenteritis was identified in farmed mink (*Mustela vison*), and within 15 years, it was observed on mink ranches throughout Canada, the United States, Europe and Scandinavia (Parrish [@CIT0019]; Pearson & Gorham [@CIT0020]); it is currently known as mink enteritis virus (MEV) (Barker & Parrish [@CIT0002]).

During the late 1970s, canine parvovirus (CPV) first emerged in domestic dogs (*Canis familiaris*), most likely as a variant of FPLV or a closely related parvovirus. Although the exact mechanism of emergence is unclear, amplification of parvovirus DNA sequences intermediate between FPLV and CPV from red foxes (*Vulpes vulpes*) suggests that wildlife may have played a role in the adaptation of the virus in a new host (Parrish [@CIT0018]; Truyen et al. [@CIT0029], [@CIT0030]). The original strain (CPV type 2) spread worldwide rapidly, shortly thereafter being replaced by type 2a and a few years later by type 2b. These two variants, however, differ very little from the original strain (Parrish [@CIT0018]; Truyen et al. [@CIT0029]). Strain CPV type 2c was diagnosed much later (\~2000), from domestic dogs in Italy, and has been proven to induce disease in cats as well (Buonavoglia et al. [@CIT0004]; Nakamura et al. [@CIT0016]).

Host range seems to be complex, as even within affected families only certain genera or species have been reported to be susceptible (Barker & Parrish [@CIT0002]). The natural hosts of CPV (dogs), FPLV (cats) and MEV (mink) have been identified; however, the natural host ranges of feline subgroup parvoviruses are poorly defined (Barker & Parrish [@CIT0002]). Wild felids that have been reported to be susceptible to FPLV include cheetah (*Acinonyx jubatus*), Siberian tiger (*Panthera tigris altaica*), African wildcat (*Felis lybica*), puma (*Puma concolor*), ocelot (*Leopardus pardalis*) and spotted cat (*Leopardus tigrinus*) (Filoni et al. [@CIT0008]; Hoelzer & Parrish [@CIT0010]; Steinel et al. [@CIT0025]). In addition, FPLV has been reported in many non-felid species, for example raccoon (*Procyon lotor*), mink (*Neovison vison*) and arctic fox (*Vulpes lagopus*) (Hoelzer & Parrish [@CIT0010]; Steinel et al. [@CIT0026]; Van Vuuren et al. [@CIT0032]).

Domestic cats have been shown to be both symptomatic and asymptomatic carriers of CPV-2a, 2b and 2c (Buonavoglia et al. [@CIT0004]; Clegg et al. [@CIT0005]; Nakamura et al. [@CIT0016]), while infection has also been demonstrated in wild felids such as cheetah and Siberian tiger (Steinel et al. [@CIT0025]). Similarly, both domestic dogs and wild canids are known to be susceptible to CPV, while antibodies against CPV have been found in coyote (*Canis latrans*), grey wolf (*Canis lupus*), maned wolf (*Chrysocyon brachyurus*), crab-eating fox (*Cerdocyon thous*), bush dog (*Speothos venaticus*), dingo (*Canis lupus dingo*), raccoon dog (*Nyctereutes procyonoides*) and African wild dog (*Lycaon pictus*) (Alexander et al. [@CIT0001]; Barker & Parrish [@CIT0002]; Van Heerden et al. [@CIT0031]).

Genetic material from FPLV has been detected in a serval (*Leptailurus serval*) with histological lesions typical for parvoviral disease and in another with salmonellosis (Lane et al. [@CIT0013]). This case explores the significance of the detection of CPV-2b in a serval from South Africa with bacterial septicaemia.

Materials and methods {#s0002}
=====================

Case presentation {#s20003}
-----------------

A captive adult male serval that presented with inappetence, anorexia, vomiting and diarrhoea was hospitalised at a veterinary practice in Nelspruit, Mpumalanga. The animal reacted well to symptomatic treatment and regained its appetite. Fifteen days later, however, it presented with epistaxis, mild icterus, anaemia (haematocrit = 28), severe leucopaenia and thrombocytopenia (subjectively evident on a blood smear). Treatment was initiated but the animal died the following day. No evidence of warfarin or other anticoagulant exposure was reported. No further clinical tests or culture were performed, and no bone marrow was submitted for evaluation or further analysis.

A necropsy showed that the serval was in good condition with mild icterus, a slightly enlarged liver and mild fluid accumulation in the body cavities. The cause of death was suspected to be because of aspiration of blood from the epistaxis. Selected tissue samples preserved in 10% buffered formalin were processed routinely and stained with haematoxylin--eosin stain. The histopathological examination confirmed septicaemia (multifocal hepatic and pulmonary necrosis associated with fine bacterial bacilli, and fibrin deposition in the splenic red pulp sinuses). Hepatic macrophages contained bile pigment in the cytoplasm. The urinary bladder mucosa showed multifocal mucosal ulceration and haemorrhage with mild submucosal lymphoplasmacytic interstitial infiltration and fibroplasia. An unspecified lymph node was mildly active and cortical follicular structures contained central hyalinisation of the stroma and possible fibrin deposition. The small intestine did not reveal any enteric lesions including changes characteristic of parvovirus-induced necrosis.

The molecular diagnostics and phylogenetic analyses formed part of a larger project at the National Zoological Garden, South African National Biodiversity Institute (NZG, SANBI), which investigates the molecular identification and genetic diversity of FPLV in both wild and domestic felids (Lane et al. [@CIT0013]). Here, we compared the serval sample (PV19) to other cases, which include PV0 to PV30 (various felids, Lane et al. [@CIT0013]), PV31 (a domestic dog from Namibia) and PV35, PV36, PV38 and PV40 (domestic dogs from Pretoria) as summarised in [Table 1](#T0001){ref-type="table"}. No domestic dog samples from Mpumalanga were available to include in the report.

###### 

Sample type, species, histopathological diagnosis and molecular analysis of parvoviral samples collected as part of the National Zoological Garden, South African National Biodiversity Institute wildlife disease database.

  Lab no.                                  Sample type   Species                    Histopathological diagnosis[†](#TFN0001){ref-type="table-fn"}   Molecular analysis
  ---------------------------------------- ------------- -------------------------- --------------------------------------------------------------- --------------------
  PV10[‡](#TFN0002){ref-type="table-fn"}   F/F           Serval                     Suspected non-FPLV                                              FPLV Clade 1
  PV15[‡](#TFN0002){ref-type="table-fn"}   FFPE          Serval                     Suspected FPLV                                                  FPLV Clade 2
  PV19                                     FFPE          Serval                     Suspected FPLV                                                  CPV-2b
  PV36                                     FFPE          Domestic dog               CPV                                                             CPV-2a
  PV38                                     FFPE          Domestic dog               CPV                                                             CPV-2a
  PV40                                     FFPE          Domestic dog               CPV                                                             CPV-2a
  PV31                                     FFPE          Domestic dog               CPV                                                             CPV-2b
  PV35                                     FFPE          Domestic dog               CPV                                                             CPV-2b
  PV1[‡](#TFN0002){ref-type="table-fn"}    F/F           African black footed cat   FPLV                                                            FPLV Clade 1
  PV24[‡](#TFN0002){ref-type="table-fn"}   FFPE          Caracal                    Suspected FPLV                                                  FPLV Clade 1
  PV0[‡](#TFN0002){ref-type="table-fn"}    F/F           Cheetah                    Suspected FPLV                                                  FPLV Clade 1
  PV4[‡](#TFN0002){ref-type="table-fn"}    FFPE          Cheetah                    FPLV                                                            FPLV Clade 1
  PV7[‡](#TFN0002){ref-type="table-fn"}    FFPE          Cheetah                    FPLV                                                            FPLV Clade 1
  PV8[‡](#TFN0002){ref-type="table-fn"}    FFPE          Cheetah                    FPLV                                                            FPLV Clade 1
  PV9[‡](#TFN0002){ref-type="table-fn"}    FFPE          Cheetah                    FPLV                                                            FPLV Clade 1
  PV11[‡](#TFN0002){ref-type="table-fn"}   F/F           Cheetah                    FPLV                                                            FPLV Clade 1
  PV12[‡](#TFN0002){ref-type="table-fn"}   F/F           Cheetah                    FPLV                                                            FPLV Clade 1
  PV26[‡](#TFN0002){ref-type="table-fn"}   F/F           Cheetah                    FPLV                                                            FPLV Clade 1
  PV27[‡](#TFN0002){ref-type="table-fn"}   Rectal swab   Cheetah                    FPLV                                                            FPLV Clade 1
  PV28[‡](#TFN0002){ref-type="table-fn"}   F/F           Cheetah                    FPLV                                                            FPLV Clade 1
  PV29[‡](#TFN0002){ref-type="table-fn"}   F/F           Cheetah                    FPLV                                                            FPLV Clade 1
  PV14[‡](#TFN0002){ref-type="table-fn"}   FFPE          Lion                       FPLV                                                            FPLV Clade 1
  PV23[‡](#TFN0002){ref-type="table-fn"}   FFPE          Lion                       FPLV                                                            FPLV Clade 1
  PV21[‡](#TFN0002){ref-type="table-fn"}   FFPE          Ocelot                     Suspected FPLV                                                  FPLV Clade 1
  PV30[‡](#TFN0002){ref-type="table-fn"}   FFPE          Caracal                    Suspected FPLV                                                  PCR negative
  PV3[‡](#TFN0002){ref-type="table-fn"}    F/F           Cheetah                    Suspected FPLV                                                  PCR negative
  PV5[‡](#TFN0002){ref-type="table-fn"}    F/F           Cheetah                    FPLV                                                            PCR negative
  PV13[‡](#TFN0002){ref-type="table-fn"}   FFPE          Cheetah                    Suspected FPLV                                                  PCR negative
  PV2[‡](#TFN0002){ref-type="table-fn"}    F/F           Domestic cat               Suspected FPLV                                                  PCR negative
  PV20[‡](#TFN0002){ref-type="table-fn"}   F/F           Leopard                    Non-FPLV                                                        PCR negative
  PV6[‡](#TFN0002){ref-type="table-fn"}    F/F           Lion                       Suspected FPLV                                                  PCR negative
  PV17[‡](#TFN0002){ref-type="table-fn"}   F/F           Lion                       Suspected FPLV                                                  PCR negative
  PV22[‡](#TFN0002){ref-type="table-fn"}   FFPE          Lion                       FPLV                                                            PCR negative
  PV25[‡](#TFN0002){ref-type="table-fn"}   F/F           Ocelot                     Non-FPLV                                                        PCR negative
  PV18[‡](#TFN0002){ref-type="table-fn"}   FFPE          Puma                       Non-FPLV                                                        PCR negative

FFPE, formalin-fixed paraffin-embedded; F/F, fresh or frozen; FPLV, feline panleucopaenia virus; CPV, canine parvovirus; PCR, polymerase chain reaction.

, Histopathological diagnosis was made on the presence of diagnostic or strongly suggestive lesions for parvoviral infection.

, Samples from Lane et al. ([@CIT0013]).

Nucleic acids from a formalin-fixed, paraffin-embedded (FFPE) intestinal sample (PV19) were extracted using the Epicentre MasterPure™ Complete DNA & RNA Purification Kit (Whitehead Scientific^®^) following the manufacturer's specifications for FFPE tissue, and deparaffinisation of FFPE samples was performed using xylene.

Molecular analysis of parvovirus from the isolate was achieved by amplification of a \~1400 bp region of the viral capsid protein (VP2) gene ([Table 2](#T0002){ref-type="table"}) using DreamTaq™ Green PCR (polymerase chain reaction) master mix (ThermoFischer Scientific) and previously published primers (Horiuchi et al. [@CIT0012]; Meers et al. [@CIT0014]; Steinel et al. [@CIT0025]; Wasieri et al. [@CIT0033]). A standard polymerase chain reaction (PCR) setup was used consisting of 8.5 *µ*L nuclease-free water (supplied with DreamTaq™), 12.5 *µ*L DreamTaq master mix, 1 *µ*L of each primer (Forward and Reverse; 10 pmol) and 2 *µ*L DNA sample standardised to a concentration of 50 ng/*µ*L. Cycling conditions for tissue isolates using primer sets 2 to 5 were as follows: initial denaturation (94 °C for 5 minutes), 30 cycles of denaturation (94 °C for 30 seconds), annealing (58 °C for 50 s) and extension (72 °C for 1 min). A final extension step (72 °C for 10 min) concluded the cycling. Cycling conditions for primer sets 1 and 6 were identical except annealing occurred at 54 °C. Conditions were adjusted for FFPE isolates by decreasing the annealing temperatures to 54 °C for primer sets 2 to 5, and 50 °C for primer sets 1 and 6. Polymerase chain reaction setup was performed in a DNA-free hood and a DNA negative control was included.

###### 

Details of sequences and amplicon size of primers used in this study for polymerase chain reaction and sequencing spanning the viral capsid protein 2 gene region.

  Primer set                                     Name                                             Sequence (5'--3')              Amplicon size (base pair)
  ---------------------------------------------- ------------------------------------------------ ------------------------------ ---------------------------
  1                                              CPV_EF[†](#TFN0003){ref-type="table-fn"}         GCCGGTGCAGGACAAGTA             421
  M2R[‡](#TFN0004){ref-type="table-fn"}          AGTTGCCAATCTCCTGGATT                                                            
  2                                              PV_VP2-1[§](#TFN0003){ref-type="table-fn"}       GAAAACGGATGGGTGGAAATC          405
  PV_VP2-2[§](#TFN0003){ref-type="table-fn"}     AGCTGCTGGAGTAAATGGCATAGT                                                        
  3                                              PV_VP2-3[§](#TFN0003){ref-type="table-fn"}       TAAAGACTGTTTCAGAATCTGCTACTCA   424
  PV_VP2-4[§](#TFN0003){ref-type="table-fn"}     AGAAATGGTGGTAAGCCCAATG                                                          
  4                                              PV_VP2-5[§](#TFN0003){ref-type="table-fn"}       ATACTGGAACTAGTGGCACACC         437
  PV_VP2-5ii[¶](#TFN0004){ref-type="table-fn"}   ATTTAAAACACCTATTGCAGCAGGAC                                                      
  5                                              PV_VP2-5iiR[¶](#TFN0006){ref-type="table-fn"}    GTCCTGCTGCAATAGGTGTTTTAAAT     440
  PV_VP2-8[§](#TFN0005){ref-type="table-fn"}     GCATCAGGATCATATTCATTTGTTAA                                                      
  6                                              Primer 22 F[††](#TFN0007){ref-type="table-fn"}   TGTCAAAATAATTGTCCTGG           564
  CPV_JS2R[†](#TFN0003){ref-type="table-fn"}     CAACCCACACCATAACAACA                                                            

PV, Parvovirus; VP2, viral capsid protein 2.

, Meers et al. [@CIT0014].

, Steinel et al. [@CIT0025].

, Wasieri et al. [@CIT0033].

, Helene Brettschneider.

, Horiuchi et al. [@CIT0012].

All positive amplicons were purified using an exonuclease I and alkaline phosphatase PCR purification protocol, sequenced using BigDye V3.1 (Applied Biosystems) chemistry and analysed on an ABI3500 genetic analyser. Sequences were aligned using the ClustalX function incorporated in MEGA6 (Tamura et al. [@CIT0028]) and phylogenetically analysed using neighbour-joining (NJ) in MEGA6. The Tamura 3-parameter model with gamma distribution (T92+G; G = 0.12) was determined to be the best-fit model of sequence evolution under the Akaike Information Criterion (AIC) in jModeltest (Posada [@CIT0022]). Phylogenetic analyses were performed on 61-taxon, trimmed to the shortest sequence (\~1200 bp), VP2 gene data set including 11 FPLV positive isolates, two FPLV vaccine strains (Fel-o-vax IV^®^, Boehringer Ingelheim; Felocell^®^, Zoetis), six CPV positive case samples and 42 parvovirus reference strains ([Table 3](#T0003){ref-type="table"}) from the National Centre for Biotechnology Information (NCBI) online database, GenBank (<https://www.ncbi.nlm.nih.gov/>). Identical field isolate sequences were selectively removed, to reduce the phylogenetic tree size, so that only representative isolates remained.

###### 

GenBank reference sequences including species, country of origin, year of collection and accession number.

  Species            Virus    Collection origin and year   Accession number
  ------------------ -------- ---------------------------- ------------------
  Cell line          CPV      Unknown; 1990                M38245
  Domestic dog       CPV-2    ITA; 2005                    FJ222824
  Vaccine            CPV-2    CHN; 2008                    FJ432718
  Fox                CPV-2    CHN; 2009                    GU392236
  Domestic dog       CPV-2    RSA; 2010                    HQ602985
  Domestic dog       CPV-2    RSA; 2010                    HQ602986
  Cell line          CPV-2a   CHN; 2007                    EU310373
  Domestic dog       CPV-2a   CHN; 2011                    JQ268283
  Domestic dog       CPV-2a   CHN; 2011                    JX660690
  Domestic dog       CPV-2a   URY; 2011                    KC196111
  Domestic dog       CPV-2a   CHN; 2009                    KF482472
  Domestic dog       CPV-2a   CHN; 2011                    KF785797
  Domestic dog       CPV-2a   CHN; 2014                    KT382542
  Domestic dog       CPV-2b   ARG; 2003                    JF414817
  Domestic dog       CPV-2c   DEU; 1997                    FJ005196
  Domestic dog       CPV-2c   BEL; 2008                    FJ005247
  Domestic dog       CPV-2c   GRC; 2008                    GQ865518
  Domestic dog       CPV-2c   URY; 2008                    KC196105
  Domestic dog       CPV-2c   ITA; 2010                    KF373598
  Domestic dog       CPV-2c   ITA; 2009                    KF385386
  Blue fox           BFPV     CHN; 2008                    GQ857595
  Domestic cat       FPLV     RSA; 1999                    AJ249556
  Cheetah            FPLV     RSA; 1999                    AJ249557
  Cell line          FPLV     RUS; 2004                    AY665655
  Vaccine Purevax    FPLV     Merial; 2008                 EU498680
  Vaccine Felocell   FPLV     Pfizer; 2008                 EU498681
  Domestic cat       FPLV     KOR; 2008                    HQ184200
  Raccoon            FPLV     US; 1978                     JN867596
  Domestic cat       FPLV     TWN; 2011                    JX048608
  Cougar             FPLV     US; 2010                     JX475253
  Domestic cat       FPLV     CHN; 2014                    KP280068
  Cell line          FPLV     US; 1988                     M24002
  Cell line          FPLV     Unknown; 1988                M24004
  Cell line          FPLV     Unknown; 1990                M38246
  Wild cat           FPLV     US; 1990                     U22187
  Cell line          MEV      RUS; 1998                    AF201477
  Cell line          MEV      CHN; 2007                    EF428258
  Mink               MEV      CHN; 2009                    GU272028
  Mink               MEV      CHN; 2010                    JX535284
  Mink               MEV      CHN; 2012                    KC713592
  Mink               MEV      CHN; 2011                    KP008112
  Mink               MEV      CHN; 2014                    KT899745

ARG, Argentina; US, United States; PRT, Portugal; URY, Uruguay; ITA, Italy; BEL, Belgium; CHN, China; GRC, Greece; DEU, Germany; TWN, Taiwan; RSA, South Africa; KOR, Korea; RUS, Russia; CPV, canine parvovirus; FPLV, feline panleucopaenia virus; BFPV, blue fox parvovirus.
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Results {#s0005}
=======

Results from the NJ analysis (1000 bootstrap replicates) illustrate a clear separation between FPLV and CPV isolates, as indicated in [Figure 1](#F0001){ref-type="fig"}. Additionally, the CPV clade consists of four distinct clusters representing CPV-2, -2a, -2b and -2c. The serval isolate from this study (PV19) grouped with the CPV-2b cluster with a domestic dog sample from the NZG, SANBI database (PV35), and with previously reported NCBI reference sequences from domestic dogs in Argentina (Gallo Calderón et al. [@CIT0009]) and South Africa (Dogonyaro et al. [@CIT0007]). Isolate PV19, however, appears to be distantly related to these isolates as indicated by the long branch length. The Namibian domestic dog isolate (PV31) from our database grouped with the CPV-2c cluster on a separate branch. Domestic dog isolates PV36, PV38 and PV40 grouped with the CPV-2a cluster also on separate branches. The majority of the South African felid samples grouped with the FPLV Clade I, including a sample from a serval with salmonellosis (PV10) (Lane et al. [@CIT0013]). The South African Clade II contained one serval with histological lesions of FPLV (PV15) with a seemingly unique viral strain (Lane et al. [@CIT0013]) that is more similar to a Felocell vaccine strain than to Clade I FPLV.

![Evolutionary relationships of detected parvoviral taxa using trimmed nucleotide sequences and the neighbour-joining method. The tree was generated using the Tamura 3-parameter model with Gamma distribution and 1000 bootstrap replicates. Cases from the NZG wildlife disease database and the study by Lane et al. ([@CIT0013]) are prefixed with laboratory numbers (PV), vaccine strains are prefixed with the vaccine name, and reference strains collected from GenBank are prefixed with the accession number. Rooted with CPV as the out-group.](JSAVA-90-1671-g001){#F0001}

Discussion {#s0006}
==========

This study reports the first detection of CPV-2b in a captive serval from South Africa, while the study by Lane et al. ([@CIT0013]) previously detected FPLV in two serval isolates. Although CPV infection has previously been detected in wild felids, such as cheetah and Siberian tiger (Steinel et al. [@CIT0025]), as well as domestic cats, the CPV-2b strain detected in the serval corresponds more closely with those detected in domestic dogs from South Africa (Dogonyaro et al. [@CIT0007]) and Argentina (Gallo Calderón et al. [@CIT0009]).

The significance of the presence of CPV and FPLV in tissues from servals with septicaemia is uncertain. Parvovirus is known to cause lymphoid necrosis and atrophy in lymphoid organs such as the thymus, gut-associated lymphoid tissue and lymph nodes as well as intestinal epithelial necrosis. The resultant immunosuppression and breach of intestinal integrity make affected animals susceptible to secondary systemic bacterial infection. Typically, domestic dogs and cats that die as a result of septicaemia secondary to parvoviral infection show histological lesions of intestinal epithelial necrosis. Detection of FPLV in a serval (PV15) with typical intestinal necrosis suggests that the disease, in FPLV at least, may show a similar course in servals. However, as domestic cats have been shown to be asymptomatic carriers of CPV-2a, -2b and -2c (Buonavoglia et al. [@CIT0004]; Clegg et al. [@CIT0005]; Nakamura et al. [@CIT0016]), we cannot rule out the possibility that servals may be asymptomatic carriers of both FPLV and CPV-2b. Alternatively, servals may at times show mild transient intestinal infections with either virus that result in immune suppression, secondary bacterial enteritis and septicaemia. This could possibly explain the 2-week period between the initial gastrointestinal signs and the terminal septicaemia in this case (PV19). It is unclear what role the damaged bladder mucosa played in this case; it may have been the route of bacterial infection.

The presence of CPV-2a and CPV-2b in the samples collected from domestic dogs from South Africa 2 years before the serval case indicates the existence of these strains in the domestic dog population in the country, and this may also indicate a likely source of infection for the serval (PV19). Information on the contact or not between domestic dogs and this serval was not available. Further investigation of samples PV36, PV38 and PV40 may reveal whether or not these isolates represent unique variants of CPV-2a. The case of CPV-2c isolated from a domestic dog sample collected in Namibia is most likely an artefact of shortening the sequences to the shortest sequence in the data set, as this virus variant has not been reported in Africa or Australia (Decaro et al. [@CIT0006]; Dogonyaro et al. [@CIT0007]; Meers et al. [@CIT0014]; Sykes [@CIT0027]). Additionally, the results of the NCBI website based Basic Local Alignment Search Tool (BLAST) which compares an input sequence to the GenBank database of sequences, identified the full length sequence of this virus as CPV-2b.

Canine parvoviruses have spread widely across the globe since the 1970s because of contact with infected animals, inanimate fomites, flies or other reservoirs (Bagshaw et al. [@CIT0003]; Barker & Parrish [@CIT0002]). Over the last 15 years (2001--2016), however, very little information about the genetic diversity of parvoviruses and possible variants in South African domestic and non-domestic carnivores has been published. The epidemiology of these viruses is therefore largely unknown, including the transmission between domestic and non-domestic species and whether or not vaccination with live virus in either group affects the epidemiology. Natural recombination has been reported in porcine, mink and rodent parvoviruses (Shackelton & Hoelzer [@CIT0023]). Similarly, recombination between FPLV and CPV-2, CPV-2a and CPV-2c, as well as vaccine and field strains has been reported but the exact mechanism is unknown (Mochizuki et al. [@CIT0015]; Ohshima & Mochizuki [@CIT0017]; Pérez et al. [@CIT0021]). Therefore, recombination remains an important factor to consider when studying the evolution and genetic diversity of parvoviruses. Extensive surveys of parvoviral strains present in wild South African carnivores, as well as domestic dogs and cats, will help determine the strain diversity, geographic and host species distribution as well as possible sources of infection. How this recombination mechanism affects vaccine efficacy is largely unknown. As it has been previously shown that domestic cats, cheetah, tiger and serval (at present) are susceptible to both CPV and FPLV, the revision of currently accepted vaccination strategies, which primarily involves vaccinating felids against FPLV only, is required.

The authors wish to thank the staff of the NZG Biobank, and Pathology section of the Department of Paraclinical Studies, Faculty of Veterinary Science, University of Pretoria. They also thank the Ann van Dyk Cheetah Centre, IDEXX Laboratories, Dr Peter Caldwell of the Old Chapel Veterinary Clinic, Dr Katja Koeppel of the Johannesburg Zoo and Dr Lucia Lange of PathCare for submitting samples to the NZG Biobank that was used in this study.

Competing interests {#s20007}
===================

The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.

Authors' contributions {#s20008}
======================

A.O. and H.B. were responsible for all the molecular work conducted and preparation of the manuscript. E.C.d.P. made the initial diagnosis and histopathological identification. E.P.M. confirmed the histopathological findings and facilitated collaboration. R.J. facilitated student supervision and edited the manuscript. D.L.D. and A.K. made sufficient resources and facilities available for the molecular and pathological work, and edited the manuscript. All authors contributed to the write-up and review of this article.

Funding information {#s20009}
===================

This study was supported by the South African National Research Foundation (NRF) with a funding grant to H.B. (grant no 80457), as well as through NZG core grant allocations for the molecular work in this study.

**How to cite this article:** Oosthuizen, A., Brettschneider, H., Dalton, D.L., Du Plessis, E.C., Jansen, R., Kotze, A. et al., 2019, 'Canine parvovirus detected from a serval (*Leptailurus serval*) in South Africa', *Journal of the South African Veterinary Association* 90(0), a1671. <https://doi.org/10.4102/jsava.v90i0.1671>
